Literature DB >> 20653736

Intracerebral large artery disease in Aicardi-Goutières syndrome implicates SAMHD1 in vascular homeostasis.

Venkateswaran Ramesh1, Bruno Bernardi, Altin Stafa, Caterina Garone, Emilio Franzoni, Mario Abinun, Patrick Mitchell, Dipayan Mitra, Mark Friswell, John Nelson, Stavit A Shalev, Gillian I Rice, Hannah Gornall, Marcin Szynkiewicz, François Aymard, Vijeya Ganesan, Julie Prendiville, John H Livingston, Yanick J Crow.   

Abstract

AIM: To describe a spectrum of intracerebral large artery disease in Aicardi-Goutières syndrome (AGS) associated with mutations in the AGS5 gene SAMHD1.
METHOD: We used clinical and radiological description and molecular analysis.
RESULTS: Five individuals (three males, two females) were identified as having biallelic mutations in SAMHD1 and a cerebral arteriopathy in association with peripheral vessel involvement resulting in chilblains and ischaemic ulceration. The cerebral vasculopathy was primarily occlusive in three patients (with terminal carotid occlusion and basal collaterals reminiscent of moyamoya syndrome) and aneurysmal in two. Three of the five patients experienced intracerebral haemorrhage, which was fatal in two individuals. Post-mortem examination of one patient suggested that the arteriopathy was inflammatory in origin.
INTERPRETATION: Mutations in SAMHD1 are associated with a cerebral vasculopathy which is likely to have an inflammatory aetiology. A similar disease has not been observed in patients with mutations in AGS1 to AGS4, suggesting a particular role for SAMHD1 in vascular homeostasis. Our report raises important questions about the management of patients with mutations in SAMHD1.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20653736     DOI: 10.1111/j.1469-8749.2010.03727.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  33 in total

1.  Aicardi goutières syndrome is associated with pulmonary hypertension.

Authors:  Laura A Adang; David B Frank; Ahmed Gilani; Asako Takanohashi; Nicole Ulrick; Abigail Collins; Zachary Cross; Csaba Galambos; Guy Helman; Usama Kanaan; Stephanie Keller; Dawn Simon; Omar Sherbini; Brian D Hanna; Adeline L Vanderver
Journal:  Mol Genet Metab       Date:  2018-09-07       Impact factor: 4.797

2.  Cerebral vasculopathy is a common feature in Aicardi-Goutieres syndrome associated with SAMHD1 mutations.

Authors:  Marcel du Moulin; Peter Nürnberg; Yanick J Crow; Frank Rutsch
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-01       Impact factor: 11.205

Review 3.  Aicardi-Goutières syndrome and the type I interferonopathies.

Authors:  Yanick J Crow; Nicolas Manel
Journal:  Nat Rev Immunol       Date:  2015-06-05       Impact factor: 53.106

Review 4.  A Multi-Model Pipeline for Translational Intracerebral Haemorrhage Research.

Authors:  Sarah E Withers; Adrian R Parry-Jones; Stuart M Allan; Paul R Kasher
Journal:  Transl Stroke Res       Date:  2020-07-07       Impact factor: 6.829

Review 5.  MDA5-Associated Neuroinflammation and the Singleton-Merten Syndrome: Two Faces of the Same Type I Interferonopathy Spectrum.

Authors:  Insa Buers; Gillian I Rice; Yanick J Crow; Frank Rutsch
Journal:  J Interferon Cytokine Res       Date:  2017-05       Impact factor: 2.607

Review 6.  Human disease phenotypes associated with mutations in TREX1.

Authors:  Gillian I Rice; Mathieu P Rodero; Yanick J Crow
Journal:  J Clin Immunol       Date:  2015-03-04       Impact factor: 8.317

7.  Aicardi-Goutières syndrome with emphasis on sonographic features in infancy.

Authors:  L Rossler; C Ludwig-Seibold; Ch Thiels; J Schaper
Journal:  Pediatr Radiol       Date:  2012-05-26

8.  Synonymous mutations in RNASEH2A create cryptic splice sites impairing RNase H2 enzyme function in Aicardi-Goutières syndrome.

Authors:  Gillian I Rice; Martin A M Reijns; Stephanie R Coffin; Gabriella M A Forte; Beverley H Anderson; Marcin Szynkiewicz; Hannah Gornall; David Gent; Andrea Leitch; Maria P Botella; Elisa Fazzi; Blanca Gener; Lieven Lagae; Ivana Olivieri; Simona Orcesi; Kathryn J Swoboda; Fred W Perrino; Andrew P Jackson; Yanick J Crow
Journal:  Hum Mutat       Date:  2013-05-13       Impact factor: 4.878

Review 9.  Therapies in Aicardi-Goutières syndrome.

Authors:  Y J Crow; A Vanderver; S Orcesi; T W Kuijpers; G I Rice
Journal:  Clin Exp Immunol       Date:  2014-01       Impact factor: 4.330

Review 10.  SAMHD1: Recurring roles in cell cycle, viral restriction, cancer, and innate immunity.

Authors:  Christopher H Mauney; Thomas Hollis
Journal:  Autoimmunity       Date:  2018-03-27       Impact factor: 2.815

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.